Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01770431 | Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy | completed | Phase 4 | 1,044 | Qidong Gaitianli Medicines Co., LtdINDUSTRY | 1 | Oct 2, 2017 | clinicaltrials |
| NCT01974661 | Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma | completed | Phase 1 | 18 | MendusINDUSTRY | 1 | Sep 29, 2017 | clinicaltrials |
| NCT03297255 |
| Primary Liver Cancer Cohort of South China |
| unknown |
| — |
| 4,000 |
| Huilian ZhuOTHER |
| 1 |
| Sep 29, 2017 |
| clinicaltrials |
| NCT02616692 | HCC Patient Preferences in Japan | completed | — | 120 | BayerINDUSTRY | 1 | Sep 27, 2017 | clinicaltrials |
| NCT00539253 | Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.(TACE) | completed | N/A | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT03292991 | REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) | unknown | — | 100 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 26, 2017 | clinicaltrials |
| NCT01751763 | Sorafenib for Residue Disease After Resection With Curative Intent(SECURE) | completed | — | 106 | BayerINDUSTRY | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01901692 | Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion(START) | completed | Phase 2 / Phase 3 | 90 | Asan Medical CenterOTHER | 1 | Sep 18, 2017 | clinicaltrials |
| NCT03235167 | Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy | unknown | Phase 1 | 100 | Dalian UniversityOTHER | 0 | Sep 18, 2017 | clinicaltrials |
| NCT02482259 | Assessment of Frailty in Patients With Advanced Hepatocellular Cancers(FAC-L) | completed | — | 28 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 1 | Sep 15, 2017 | clinicaltrials |
| NCT02830737 | No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma | unknown | N/A | 178 | Southwest Hospital, ChinaOTHER | 1 | Sep 15, 2017 | clinicaltrials |
| NCT03083002 | Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis | unknown | — | 250 | University of Modena and Reggio EmiliaOTHER | 1 | Sep 13, 2017 | clinicaltrials |
| NCT02042443 | Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery(S1310) | completed | Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Sep 12, 2017 | clinicaltrials |
| NCT03273608 | Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients | unknown | — | 120 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 6, 2017 | clinicaltrials |
| NCT02585687 | Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma(ETAFIRM) | terminated | N/A | 28 | Hospices Civils de LyonOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01489410 | Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma | withdrawn | N/A | 0 | University of MinnesotaOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT00096733 | Adult-to-Adult Living Donor Liver Transplantation Study(A2ALL-1) | completed | — | 2,470 | Arbor Research Collaborative for HealthOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01008657 | Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular Technique(ARMCENVIN) | completed | N/A | 216 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03261791 | Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT00701168 | Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer | no longer available | — | — | Leo W. Jenkins Cancer CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT01668017 | A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy | terminated | Phase 1 | 26 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Aug 23, 2017 | clinicaltrials |
| NCT00629421 | Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study | completed | — | 1,200 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02821533 | Chemoembolization for Hepatocellular Carcinoma | terminated | Phase 2 | 24 | Chinese University of Hong KongOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT01247298 | A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma(RAD 0902) | completed | Early Phase 1 | 17 | University of Alabama at BirminghamOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT03253536 | Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma(LIVERCARE) | recruiting | — | 100 | Ludwig-Maximilians - University of MunichOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT01191385 | GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start | withdrawn | — | 0 | BayerINDUSTRY | 1 | Aug 16, 2017 | clinicaltrials |
| NCT02007954 | Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma(DEBDOX) | completed | Phase 2 | 24 | Yale UniversityOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection(HAICAT) | unknown | Phase 2 / Phase 3 | 192 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT03243916 | Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC | unknown | N/A | 40 | Chinese PLA General HospitalOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT02959359 | DAA in the Risk of Recurrence After Curative Treatment of HCC | withdrawn | Phase 4 | 0 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 0 | Aug 7, 2017 | clinicaltrials |
| NCT00706576 | Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor | completed | Phase 1 | 14 | University of Missouri-ColumbiaOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT01375569 | TRC105 for Liver Cancer That Has Not Responded to Sorafenib | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02089633 | Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC(PACOX) | completed | Phase 2 | 17 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Jul 28, 2017 | clinicaltrials |
| NCT03227510 | MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients | unknown | — | 126 | People's Friendship University of RussiaOTHER | 0 | Jul 25, 2017 | clinicaltrials |
| NCT00920192 | Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer | completed | Phase 1 | 45 | GlaxoSmithKlineINDUSTRY | 3 | Jul 18, 2017 | clinicaltrials |
| NCT01639703 | Hepatic Xenetix-CT Perfusion | completed | Phase 4 | 96 | GuerbetINDUSTRY | 4 | Jul 13, 2017 | clinicaltrials |
| NCT01639352 | Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 2 | 20 | Lynn FeunOTHER | 1 | Jul 12, 2017 | clinicaltrials |
| NCT01456156 | Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma | completed | N/A | 76 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT03208335 | Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) | unknown | Phase 2 | 61 | Chinese PLA General HospitalOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT02644603 | Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer | unknown | N/A | 214 | Shanghai Zhongshan HospitalOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT03198975 | Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma | unknown | — | 40 | Ming KuangOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00861783 | Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma | completed | Phase 1 | 16 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 23, 2017 | clinicaltrials |
| NCT03197155 | Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence(RECAR) | completed | — | 68 | Hospices Civils de LyonOTHER | 0 | Jun 23, 2017 | clinicaltrials |
| NCT01393093 | Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas(TACE-KMG) | unknown | N/A | 2,840 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT03178929 | Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | unknown | N/A | 207 | Beijing Insight Science & Technology Co. Ltd.OTHER | 0 | Jun 7, 2017 | clinicaltrials |
| NCT03178409 | Combined HCC-MFCCC | completed | — | 100 | University of MilanOTHER | 0 | Jun 6, 2017 | clinicaltrials |
| NCT00787787 | Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer | terminated | Phase 2 | 41 | University of WashingtonOTHER | 1 | Jun 1, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Oct 2, 2017source: clinicaltrials